EMEA-001563-PIP02-15-M01
Key facts
| Active substance |
ciprofloxacin hydrochloride
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0253/2018
|
| PIP number |
EMEA-001563-PIP02-15-M01
|
| Pharmaceutical form(s) |
Nebuliser solution
|
| Condition(s) / indication(s) |
Treatment of chronic pulmonary infections caused by Pseudomonas aeruginosa
|
| Route(s) of administration |
Inhalation use
|
| Contact for public enquiries |
Savara ApS
E-mail: mette.vinge@savarapharma.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|